Empirical and theoretical phenotypic discrimination

Journal of Thrombosis and Haemostasis

Volumn 7, Issue SUPPL. 1, 2009, Pages 181-186

  Brummel Ziedins, Kathleen E ^a   Orfeo, T ^a   Rosendaal, F R ^b   Undas, A ^c   Rivard, G E ^d   Butenas, S ^a   Mann, K G ^a  

^a UNIVERSITY OF VERMONT   (United States)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^c JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^d CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Blood coagulation; Computational; Empirical; Models; Phenotype; Thrombin generation

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; BLOOD CLOTTING FACTOR 8C; THROMBIN; THROMBIN ANTITHROMBIN COMPLEX;

ACUTE CORONARY SYNDROME; BLEEDING; BLOOD CLOTTING; CLINICAL ARTICLE; CONTROLLED STUDY; HEMOPHILIA A; HEMOSTASIS; HUMAN; MATHEMATICAL MODEL; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REVIEW; RISK ASSESSMENT; THROMBIN TIME; THROMBOGENESIS; THROMBOSIS;

COMPUTATIONAL BIOLOGY; EMPIRICAL RESEARCH; HEMORRHAGE; HEMOSTASIS; HUMANS; MODELS, THEORETICAL; PHENOTYPE; THROMBIN; THROMBOSIS;

EID: 67849106556     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2009.03426.x     Document Type: Review

References (45)

1. Dickson BC. Venous thrombosis: On the history of Virchow's triad. Univ Toronto Med J 2004; 81: 166-71.
2. Brummel-Ziedins K, Orfeo T, Jenny NS, Everse SJ, Mann KG. Blood coagulation and fibrinolysis. In: Greer JP, Foerster J, Lukens J, Rodgers GM, Paraskevas F, Glader B, eds. Wintrobe's Clinical Hematology. Philidelphia: Lippencott Williams & Wilkins, 2003: 677-774.
3. Mannucci PM, Tuddenham EGD. The hemophiliacs-from royal genes to gene therapy. N Engl J Med 2001; 344: 1733-79.
4. Hoyer LW. Hemophilia A. N Engl J Med 1994; 330: 38-47.
5. Reitsma PH. Protein C deficiency: From gene defects to disease. Thromb Haemost 1997; 78: 344-50.
6. Bertina RM, Koeleman BP, Koster T, Rosendaal FR, Dirven RJ, de Ronde H, van der Velden PA, Reitsma PH. Mutation in blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-7.
7. White RH. The epidemiology of venous thromboembolism. Circulation 2003; 107: I4-8.
8. Davie EW, Kulman JD. An overview of the structure and function of thrombin. Semin Thromb Hemost 2006; 32 (Suppl. 1): 3-15.
9. Jenny NS, Mann KG. Thrombin. In: Colman RW, Hirsh J, Marder VJ, Clowes AW, George JN, eds. Hemostasis and Thrombosis; Basic Principles & Clinical Practice. Philadelphia: Lippincott Williams & Wilkins, 2001: 171-89.
10. Hemker HC, Giesen P, AlDieri R, Regnault V, de Smed E, Wagenvoord R, Lecompte T, Beguin S. The calibrated automated thrombogram (CAT): A universal routine test for hyper- and hypocoagulability. Pathophysiol Haemost Thromb 2002; 32: 249-53.
11. Sorensen B, Ingerslev J. Whole blood clot formation phenotypes in hemophilia A and rare coagulation disorders. Patterns of response to recombinant factor VIIa. J Thromb Haemost 2004; 2: 102-10.
12. Brummel-Ziedins K, Rivard GE, Pouliot RL, Butenas S, Gissel M, Parhami-Seren B, Mann KG. Factor VIIa replacement therapy in factor VII deficiency. J Thromb Haemost 2004; 2: 1735-44.
13. Dargaud Y, Luddington R, Baglin T. Platelet-dependent thrombography: A method for diagnostic laboratories. Br J Haematol 2006; 134: 323-5.
14. Wolberg AS, Allen GA, Monroe DM, Hedner U, Roberts HR, Hoffman M. High dose factor VIIa improves clot structure and stability in a model of haemophilia B. Br J Haematol 2005; 131: 645-55.
15. Regnault V, Hemker HC, Wahl D, Lecompte T. Phenotyping the haemostatic system by thrombography-potential for the estimation of thrombotic risk. Thromb Res 2004; 114: 539-45.
16. Beltran-Miranda CP, Khan A, Jaloma-Cruz AR, Laffan MA. Thrombin generation and phenotypic correlation in haemophilia A. Haemophilia 2005; 11: 326-34.
17. Hron G, Kollars M, Binder BR, Eichinger S, Kyrle PA. Identification of patients at low risk for recurrent venous thromboembolism by measuring thrombin generation. JAMA 2006; 296: 397-402.
18. Mann KG, Whelihan MF, Butenas S, Orfeo T. Citrate anticoagulation and the dynamics of thrombin generation. J Thromb Haemost 2007; 5: 2055-61.
19. DE Smedt E, Wagenvoord R, Coen HH. The technique of measuring thrombin generation with fluorogenic substrates: 3. The effects of sample dilution. Thromb Haemost 2009; 101: 165-70.
20. Brummel-Ziedins K, Whelihan MF, Ziedins EG, Mann KG. The resuscitative fluid you choose may potentiate bleeding. J Trauma 2006; 61: 1350-8.
21. Luddington R, Baglin T. Clinical measurement of thrombin generation by calibrated automated thrombography requires contact factor inhibition. J Thromb Haemost 2004; 2: 1954-9.
22. Rand MD, Lock JB, van't Veer C, Gaffney DP, Mann KG. Blood clotting in minimally altered whole blood. Blood 1996; 88: 3432-45.
23. Brummel KE, Paradis SG, Butenas S, Mann KG. Thrombin functions during tissue factor-induced blood coagulation. Blood 2002; 100: 148-52.
24. Butenas S, Brummel KE, Branda RF, Paradis SG, Mann KG. Mechanism of factor VIIa-dependent coagulation in hemophilia blood. Blood 2002; 99: 923-30.
25. Hockin MF, Jones KC, Everse SJ, Mann KG. A model for the stoichiometric regulation of blood coagulation. J Biol Chem 2002; 277: 18322-33.
26. Brummel-Ziedins KE, Vossen CY, Butenas S, Mann KG, Rosendaal FR. Thrombin generation profiles in deep venous thrombosis. J Thromb Haemost 2005; 3: 2497-505.
27. van Boven HH, Lane DA. Antithrombin and its inherited deficiency states. Semin Hematol 1997; 34: 188-204.
28. Lu D, Bovill EG, Long GL. Molecular mechanism for familial protein C deficiency and thrombosis in protein C Vermont (Glu20->Ala and Val34->Met). J Biol Chem 1994; 269: 29032 --8.
29. Koster T, Blann AD, Briet E, Vandenbroucke JP, Rosendaal FR. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep-vein thrombosis. Lancet 1995; 345: 152-5.
30. van Hylckama V, van der Linden I, Bertina RM, Rosendaal FR. High levels of factor IX increase the risk of venous thrombosis. Blood 2000; 95: 3678-82.
31. Lavigne G, Mercier E, Quere I, Dauzat M, Gris JC. Thrombophilic families with inheritably associated high levels of coagulation factors VIII, IX and XI. J Thromb Haemost 2003; 1: 2134-9.
32. Adams TE, Everse SJ, Mann KG. Predicting the pharmacology of thrombin inhibitors. J Thromb Haemost 2003; 1: 1024-1027.
33. Butenas S, Orfeo T, Brummel-Ziedins KE, Mann KG. The influence of bivalirudin on tissue factor-initiated thrombin generation. Blood Coagul Fibrinolysis 2007; 18: 407-414.
34. Brummel-Ziedins KE, Pouliot RL, Mann KG. Thrombin generation: Phenotypic quantitation. J Thromb Haemost 2004; 2: 281-8.
35. Butenas S, Orfeo T, Mann KG. Synergistic antagonists for hemophilia treatment. J. Thromb. Haemost 3 [S1] 2005
36. Brummel-Ziedins KE, Gissel M, Francis C, Queenan J, Mann KG. The effect of high circulating estradiol levels on thrombin generation during in vitro fertilization. Thromb Res 2009 Mar 16. [Epub ahead of print].
37. Everse SJ, Orfeo T, Brummel-Ziedins KE, Hockin MF, Mann KG. Predicting thrombosis in factor V Leiden heterozygotes. Blood 2008; 81: 112-1818.
38. Brummel-Ziedins K, Vossen CY, Rosendaal FR, Umezaki K, Mann KG. The plasma hemostatic proteome: Thrombin generation in healthy individuals. J Thromb Haemost 2005; 3: 1472-81.
39. Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation 1995; 92: 657-71.
40. Harrington RA, Becker RC, Ezekowitz M, Meade TW, O'Connor CM, Vorchheimer DA, Guyatt GH. Antithrombotic therapy for coronary artery disease: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 2004; 126: 513S-48S.
41. Brummel-Ziedins K, Undas A, Orfeo T, Gissel M, Butenas S, Zmudka K, Mann KG. Thrombin generation in acute coronary syndrome and stable coronary artery disease: Dependence on plasma factor composition. J Thromb Haemost 2008; 6: 104-10.
42. Mannucci PM. Hemophilia: Treatment options in the twenty-first century. J Thromb Haemost 2003; 1: 1349-55.
43. Aledort L. Why thrombin generation? From bench to bedside. Pathophysiol Haemost Thromb 2003; 33: 2-3.
44. Ahlberg A. Haemophilia in Sweden.VII. Incidence, treatment, and prophylaxis of arthropathy and other musculoskeletal manifestations of hemophilia A and B. Acta Orthop Scand 1965; 77: 3-132.
45. Brummel-Ziedins KE, Whelihan MF, Gissel M, Mann KG, Rivard GE. Thrombin generation and bleeding in hemophilia A. Haemophilia 2009; in press.